BioCentury
ARTICLE | Company News

Allergan, The Centre for Applied Microbiology & Research deal

May 22, 2000 7:00 AM UTC

AGN received an exclusive license to commercialize CAMR technology that is based on modifying neurotoxins produced by Clostridium botulinum to treat acute and chronic pain. CAMR will receive up to £20...